Rani’s “robotic” pill incorporates a number of innovations, enabling it to navigate through the stomach and enter the small intestine. The RaniPill™ capsule goes through a transformation and aligns itself and injects the drug into the intestinal wall.
Delivered through the highly vascularized intestinal wall.
The self-inflating balloon has been designed to minimize GI discomfort.
Vertically integrated manufacturing strategy allows for rapid product iteration and the ability to rapidly scale manufacturing capacity.
Can accommodate therapeutic peptides, proteins, antibodies and nucleotides.
The RaniPill™ capsule demonstrates encouraging results in humans.
Covering both the platform and drugs in combination with the platform.
The RaniPill™capsule moves through the stomach – where acids typically break down drugs – intact and then reaches the intestine where it delivers the drug into the intestinal wall. The highly vascularized intestinal wall allows the drug to be absorbed rapidly.